Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ardent Health, Inc. (ARDT : NYSE)

• Company Description    Ardent Health Partners Inc. is a provider of healthcare. Ardent Health Partners Inc., formerly known as ARDENT HEALTH, is based in BRENTWOOD, Tenn. Number of Employees: 25,200

• Price / Volume Information    Yesterday's Closing Price: $9.23 Daily Weekly Monthly 20 Day Moving Average: 427,856 shares Shares Outstanding: 143.35 (millions) Market Capitalization: $1,323.12 (millions) Beta: 0.93 52 Week High: $15.48 52 Week Low: $8.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -4.65% -9.31% 12 Week -2.64% -9.99% Year To Date 4.53% -4.10%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 340 SEVEN SPRINGS WAY SUITE 100 - BRENTWOOD,TN 37027 USA ph: 615-296-3000 fax: - investor.relations@ardenthealth.com http://www.ardenthealth.com

• General Corporate Information    Officers Martin J. Bonick - President and Chief Executive Officer; Director Alfred Lumsdaine - Chief Financial Officer David Byers - Senior Vice President Mark Sotir - Director Peter Bulgarelli - Director Peer Information Ardent Health, Inc. (CHCR) Ardent Health, Inc. (ESRX) Ardent Health, Inc. (MYDP) Ardent Health, Inc. (COR) Ardent Health, Inc. (GBCS) Ardent Health, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 03980N107 SIC: 8062 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 143.35 Most Recent Split Date: (:1) Beta: 0.93 Market Capitalization: $1,323.12 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.25 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $1.12 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 4.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: 8.21 Trailing 12 Months: 5.63 PEG Ratio: 2.05 Price Ratios Price/Book: 0.76 Price/Cash Flow: 3.36 Price / Sales: 0.21 EPS Growth vs. Year Ago Period: -3.45% vs. Previous Quarter: -12.50% Sales Growth vs. Year Ago Period: 6.99% vs. Previous Quarter: -0.20% ROE 03/31/26 - 13.85 12/31/25 - 14.30 09/30/25 - 19.02 ROA 03/31/26 - 4.48 12/31/25 - 4.58 09/30/25 - 6.04 Current Ratio 03/31/26 - 2.12 12/31/25 - 1.97 09/30/25 - 2.08 Quick Ratio 03/31/26 - 2.00 12/31/25 - 1.85 09/30/25 - 1.95 Operating Margin 03/31/26 - 3.61 12/31/25 - 3.69 09/30/25 - 4.79 Net Margin 03/31/26 - 2.09 12/31/25 - 2.15 09/30/25 - 3.24 Pre-Tax Margin 03/31/26 - 4.46 12/31/25 - 4.53 09/30/25 - 5.71 Book Value 03/31/26 - 12.10 12/31/25 - 11.78 09/30/25 - 11.41 Inventory Turnover 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Equity 03/31/26 - 0.62 12/31/25 - 0.64 09/30/25 - 0.67 Debt-to-Capital 03/31/26 - 38.12 12/31/25 - 38.92 09/30/25 - 39.93

Powered by Zacks Investment Research ©